Sign In

ACS News

Breaking News

Campus Relay For Life Fund the Mission Challenge smashes fundraising goal

Another successful Campus Relay For Life Fund the Mission Challenge recently surpassed its $200,000 goal thanks to our next generation of volunteer leaders. Organized by the Volunteer National Campus and Youth Engagement Team, this 72-hour fundraising challenge for all high school and college Campus Relay For Life events took place from Feb. 11-13 and raised more than $271,740.

​This is the highest amount raised in over five years and an increase of almost $70,000. 

​Beginning in 2012, the annual challenge encourages attendees and volunteers to compete for top prizes right before the event season starts.

Categories for the 2025 challenge included:

  • Top Fundraising College Event 
  • Top Fundraising High School Event ​
  • ​​​​Second and third place College and High School Fundraising Events
  • Top Year Over Year Growth Event 
  • Top 10 Fundraising Participant, College 
  • ​​​Top 10 Fundraising Participant, Youth 

Events/chapters that raised $2,500 or more during the challenge are also entered to win a chance to attend the Campus Relay For Life Leadership Summit in July 2025.

Special congratulations to:

  • ​Our Top Fundraising College Event: Relay For Life of Coastal Carolina University (Chinel Boateng, senior development manager)
  • Top Fundraising High School Event: Relay For Life of Mission San Jose (Haley Huntington, senior development manager)
  • Relay For Life of Coastal Carolina University also won the Top Year Over Year Growth category this year with 23.6% growth. 
This year's challenge also kicked off with a registration challenge discount day which resulted in 1,412 volunteers registering for a campus Relay For Life event in the 24-hour window. 

  • ACS is now on the DonorDrive Charity Fundraising app

    ​As technology continues to shape the nonprofit sector, ACS recognizes that mobile fundraising apps represent the next evolution in digital giving. We are excited to share that, as of Feb. 10, DIY fundraisers for ACS can now download and fundraise on the DonorDrive Charity Fundraising App, providing participants with an innovative way to engage, raise funds, and maximize their impact. Designed to meet fundraisers where they are, this cutting-edge app enhances convenience, fosters deeper connections with donors, and ultimately drives revenue for the mission. 

    The mobile fundraising app offers a seamless experience for users to set up personal fundraising pages, track donations in real-time, and share their campaigns across social media and messaging platforms – all on the go. 

    Key features:
    • With built-in messaging tools, automated donation acknowledgments, and progress-tracking capabilities, fundraisers can keep their donors informed and engaged throughout their campaigns. 
    • ​Integrated gamification elements, such as leaderboards, milestone badges, and fundraising challenges, further incentivize participation and inspire healthy competition among fundraisers. 
    With more people relying on their mobile devices for everyday tasks, this intuitive, user-friendly app ensures our DIY fundraisers can meet donors where they are and maximize their outreach efforts.

    To learn more and get started, visit the DonorDrive website. ​​​​​

  • Here’s the bottom line for Colorectal Cancer Awareness Month

    The American Cancer Society is raising awareness about early detection for colorectal cancer during Colorectal Cancer Awareness Month in March. Colorectal cancer is the leading cause of death in men and the second in women under 50 years old. Even more alarming, only about 20 percent of people ages 45-49 are getting screened for colorectal cancer. 

    Colorectal Cancer Screening Saves Lives

    Here’s the bottom line: Colorectal cancer has a 91% survival rate when found early. If you’re 45 or older and don’t have symptoms, now is the perfect time to show yourself some love and get screened. 

    Regular colorectal cancer screening can find and remove lesions before they become cancer, and everyone age 45 and older is encouraged to talk to a doctor about colorectal cancer screening. 

    The ACS I Love You Get Screened activation will drive awareness of colorectal cancer and drive people to talk to a doctor and visit cancer.org/getscreened.

    If you’re age 45+, talk to a doctor about colorectal cancer screening. 
    • ​​Share information about screening with your friends and family. 
    • Engage and share information from ACS brand social channels. 
    • Learn more at cancer.org/getscreened. 
    • ​Use the ACS CancerRisk360 tool to assess your risk and share the tool with others. There’s no sure way to prevent colorectal cancer, but you may be able to lower your risk for colorectal cancer by changing the risk factors you can control.
    ​Colorectal Cancer Facts 
    • ​​​Cancer screening is for people without symptoms. 
    • Only 20% of people aged 45-49 years are getting screened for colorectal cancer. 
    • When colorectal cancer is found at an early stage before it has spread, the 5-year relative survival rate is about 90%. 
    • There are several testing options for colorectal cancer screening – the most important thing is to get screened, no matter which test you choose. 
    • About 1 in 3 people in the United States who should get tested for colorectal cancer have never been screened. 
    • Regular colorectal cancer screening can find and remove lesions before they become cancer. 
    • Colorectal cancer is the second most common cause of cancer death in men and women combined. 
    • Screening can prevent colorectal cancer through the detection and removal of precancerous growths (polyps), and it can often detect cancer at an early stage, when treatment is usually more successful. 
    • More than half of all colorectal cancers in the US are attributable to potentially modifiable risk factors, such as smoking, an unhealthy diet, high alcohol consumption, physical inactivity, and excess body weight. 
    • If 80% of the eligible population stayed up to date with screening, more than a quarter of a million (277,000) colorectal cancer cases and 203,000 deaths could be prevented. 

  • New ACS study shows cancer mortality rates among Black People declining, but remain higher than other racial and ethnic groups

    Today, the American Cancer Society (ACS) released Cancer Statistics for African American and Black People, 2025. The report shows a decline in cancer mortality rate from 1991 to 2022 by 49% and 33% in African American or Black men and women, respectively, in the United States. However, African American and Black people continue to face a disproportionately elevated cancer burden compared to other populations. According to the study, the risk of cancer death for African American or Black individuals is two-fold that of White individuals for myeloma, prostate, uterine corpus (endometrial), and stomach cancers, and 40% to 50% higher for colorectal, breast, cervical, and liver cancers. Similarly, survival is lower in Black people than in White people for almost every type and stage of cancer, with the most significant gaps for melanoma, uterine corpus, and cervical cancers. These crucial findings are published in CA: A Cancer Journal for Clinicians and available on cancer.org

    “Overall declines in cancer mortality rates in Black people largely reflect behavioral changes, such as historical declines in cigarette smoking among Black teens, as well as advances in treatment and earlier detection for some cancers,” said Rebecca Siegel, senior scientific director, surveillance research at ACS, and senior author of the report. “Yet, this population persistently experiences a much higher mortality burden than other racial and ethnic groups for many cancers. We must reverse course.”

    This year, there will be an estimated 248,470 new cancer diagnoses and 73,240 cancer deaths among this population. Cancer is the second-highest cause of death in African American and Black men and women after heart disease. 
     
    "This report highlights the disparities the Black community has faced for decades. While the decline in cancer mortality rates is encouraging, the stark inequities in incidence and survival for many cancers underscore the urgent need for targeted research and interventions,” said Dr. Wayne A. I. Frederick, interim chief executive officer of ACS and American Cancer Society Cancer Action Network (ACS CAN). “This is a critical opportunity for the scientific, clinical, and policy-making community to come together to drive meaningful change. Together, we must inform strategies to close these gaps, improve early detection, and ensure equitable access to lifesaving treatments for the Black community.” 

    Other highlights in the report include: 

    • Black men experienced the most significant relative decline in cancer mortality from 1991 to 2022 (compared to Black women and White men and women) at nearly every age, including a 65% to 67% drop among those 40-59 years of age. 
    • The most commonly diagnosed cancers continue to be prostate (44% among males), breast (34% among females), lung (10%), and colorectal (8%), which will account for 58% of all new cancers diagnosed among Black people. 
    • Black men have a 67% higher prostate cancer incidence rate compared to White men and are more than twice as likely to die from the disease. 
    • Black women have a 38% higher likelihood of dying from breast cancer compared to White women despite a 5% lower likelihood of being diagnosed with the disease. 
    • Uterine corpus (endometrial) cancer incidence continues to increase in Black women by 2% per year. 

    “Future research should not only explore the influence of systemic racism on health but also develop mechanisms to implement change, including increasing diversity in clinical trials,” added Dr. William Dahut, chief scientific officer at ACS.

    Other ACS researchers​ participating in the study include lead author Anatu Saka, Angela Giaquinto, Dr. Lauren McCullough, and Dr. Ahmedin Jemal.

  • Senate legislation addresses prostate cancer screening costs

    On Feb. 13​, the Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act was introduced in the United States House of Representatives by Representatives Neal Dunn, MD (R-FL) and Yvette Clarke (D-NY) with Representatives Greg Murphy (R-NC) and Troy Carter (D-LA) as cosponsors. Last week, Senator John Boozman (R-AR) introduced it in the United States Senate, along with Senator Cory Booker (D-NJ).

    This bipartisan legislative proposal would waive cost-sharing requirements for men with the highest risk of prostate cancer, focusing on those with a family history of the disease. For men who have a family history of prostate cancer, a diagnosis is twice as likely compared to the average population. If this bill passes, men at an increased risk of developing prostate cancer would be able to receive prostate cancer screening without deductibles, copayments, or coinsurances.​

    Prostate cancer is the second leading cause of cancer death for men in the U.S. When the disease is detected early, the 5-year survival rate is nearly 100%. However, when the disease is detected in advanced stages, the likelihood of survival drops to just 37%. 

    The American Cancer Society Cancer Action Network (ACS CAN) supports the PSA Screening for HIM Act and is working with lawmakers to pass legislation at both the state and federal levels that will eliminate out-of-pocket costs for patients and improve access to prostate cancer screening tests. 

    “Out of pocket costs can be a major obstacle to accessing screening,” said Dr. Wayne A. I. Frederick, interim chief executive officer of the American Cancer Society and ACS CAN. “The PSA Screening for HIM Act will help remove this barrier and enable those at high risk to get the prostate cancer screening tests they need to detect prostate cancer at the earliest, most treatable stage.” 

    The PSA Screening for HIM Act could also help improve health outcomes for those at the highest risk of prostate cancer. According to the American Cancer Society, the incidence of prostate cancer among Black men is almost 70% higher than in White men. Black men are also more than twice as likely to die from prostate cancer when compared to White men. Moreover, having a first-degree relative (father or brother) with prostate cancer more than doubles the chance of developing the disease. 

    “Everyone should have a fair and just opportunity to prevent, detect, treat and survive cancer,” said Dr. Frederick. “We urge the Senate to pass this legislation to help save more lives.” 

    Like and share on X

  • Making Strides 2024 awards celebrate stand-out events and supporters

    It is officially awards season, and Making Strides Against Breast Cancer events and supporters were honored the week of February 10. Several national awards seek to honor and recognize all those who have gone above and beyond to help drive the American Cancer Society's vision to end cancer as we know it, for everyone, through the Making Strides Against Breast Cancer movement.

    The Spirit of Strides Awards are intended to honor and recognize an event, individual, and team that embody the relentless Making Strides spirit and commitment that has propelled the success for this movement. Additional details on the award winners can be found on ACSResources. Congratulations to the following Spirit of Strides winners.

    Strides Event of the Year: Making Strides of Santa Monica

    Strider of the Year: Carol Cote, Making Strides of Phoenix

    Strides Team of the Year: O Positiv Health (Making Strides of Santa Monica)

    Data-Determined Awards are solely based on data collected in ACS records.

    Select Fundraising and Data-Determined Award Winners

    #1 Net Income Event
    • Making Strides Against Breast Cancer of Long Island, NYC - $2.4 million​

    ​Nationwide Top Company Team

    • NYSUT/UFT
    Top 5 Nationwide Teams (Full list available on ACSResources.org)

    • AutoZone Striders: $244,604 – Making Strides of Memphis
    • Ergon, Inc.: $229,447 – Making Strides of Central Mississippi
    • Ricoh Striders: $211,351 – Making Strides of Atlanta
    • Answer to Cancer SRG: $209,333 – Making Strides of Sarasota Manatee
    • Team CITY Cares – Broward: $163,815 – Making Strides of Broward County
    #1 Nationwide Individual Fundraiser
    • Larry Tomkins: $223,285 - Making Strides of Central Mississippi
    ​Making Strides Champion of Mission Award
    • Ricoh Striders – Making Strides of Atlanta
    Making Strides Hero of Research Award
    • Ergon, Inc. – Making Strides of Central Mississippi
    Many thanks and congratulations to all the 2024 Making Strides Against Breast Cancer award winners! 

  • February Advocacy Update

    ​With new and returning elected officials in Congress and the new Administration moving at pace, ACS CAN is navigating the flurry of activity and shifting priorities in our nation's capital. While we continue to see new developments daily that may impact our strategies, our mission remains unchanged, and priority work on behalf of cancer patients and their families demands our unwavering attention. 

    Some recent executive acti​ons and legislative and regulatory proposals at both federal and state levels are directly related to programs important to our cancer mission, as well as challenge our core values of inclusion and health equity. As we work to understand specifics, ACS CAN is committed to engaging policymakers to ensure that everyone has the chance to prevent, detect, treat, and survive cancer. We are monitoring developments at federal, state, local, and judicial levels, and our priority work continues, rooted in scientific evidence that supports policy interventions that reduce the cancer burden nationwide. 

    At the federal level, we have launched a strategic 100-day campaign to advocate for our highest priorities. ACS CAN is advocating for uninterrupted, sustained, and robust funding for cancer research and affordable access to comprehensive health care. We are actively urging opposition to any cuts or barriers that compromise access to Medicaid. Lawmakers have specifically identified significant changes to the Medicaid program because of savings that can be generated. 

    As you know, ACS CAN has long advocated for expanded access to care through Medicaid, most recently through our Medicaid Covers US campaign, where we are continuing our efforts to expand the program in the remaining 10 states that have not yet acted. Evidence is clear that health insurance is one of the most important determinants of surviving cancer and Medicaid is a lifeline for many cancer patients, survivors, and their families. Therefore, we will be urging Congress to reject any proposals that compromise access to health insurance through Medicaid.
     
    This week, we launched a petition asking volunteers to urge their lawmakers to protect Medicaid. Volunteer leadership teams have also been delivering our First 100 Days priorities directly to district offices, which will be coupled with other impactful campaign strategies over the coming weeks and months. 

    ​Across the country, 48 states are in session, and our Cancer Action Days are underway. In states we continue to focus our priorities on expanding access to patient navigation services, ensuring coverage of biomarker testing, reducing the burden of medical debt, increasing prevention measures, and protecting and expanding Medicaid. 

    Your support is critical! Please lend your voice and help us through your advocacy as we navigate this year's political landscape to elevate the patient voice and our cancer issues to lawmakers. 

    Thank you for your ongoing commitment to our vision to end cancer as we know it, for everyone. 

    - ​ACS CAN President, Lisa Lacasse​

    Celebrating Black History Month 

    This February marks the 49th annual celebration of Black History Month. We’re commemorating this Black History Month by highlighting the importance of health equity and policies that increase equitable access to cancer care for all, raising awareness of cancer disparities in the Black community, spotlighting the pivotal work of our Black volunteers, and honoring Black figures who have made invaluable contributions to health equity and cancer care. Follow along on our social channels for more​

    Team Spotlight

    Last month, New Jersey Government Relations Director Quinton Law was sworn in as mayor of his hometown of Mooresto​​wn, NJ. He is the first Black mayor in the town's history. Quinton was inaugurated in the meeting hall of the Town Council, which was bursting with spectators who were there to support. In his first remarks as mayor, Law expressed great pride as a native of Moorestown and gratitude for the responsibility to build on its legacy of unity and prosperity. We at ACS CAN could not be prouder of Quinton!

    In Case You Missed It

    ACS CAN was honored to screen In Due Season at the Families USA Health Action Conference in Washington, D.C. Legislative ambassador Neidre Fears, featured in the film, joined ACS CAN's Tomica Smith and Kristen Keifer for the event. Tomica introduced the film to a captivated audience, followed the next day by a powerful panel discussion on Medicaid expansion and health equity. A heartfelt thank you to ACS CAN team members Hillary Clarke, Mills Sparkman, Lizzy Salinas, and Katie Riley for their support at the exhibitor booth and throughout the conference.

    ​Survivor Views - ACS CAN Released New Data focused on Premium Tax Credits

    According to ACS CAN's latest Survivor Views survey, 86% of cancer patients and survivors who are able to purchase their health insurance on the Marketplace due to tax credits say they would have difficulty getting the care they need without these enhanced premium tax credits. Many of those who responded say they would consider alternatives plans that expose them to greater financial or health risk, such as enrolling in high deductible plans (81%), or plans with less coverage (69%). Further, only 25% were aware before the survey that the enhanced credits are set to expire at the end of 2025.

    Cost Barriers Associated with Diagnostic Tests for Breast Cancer

    ​A new report by ACS CAN reveals that over 70% of commercially-insured breast cancer patients faced out-of-pocket costs for follow-up diagnostic tests in 2023. These tests, such as mammograms, MRIs, ultrasounds, or biopsies, are necessary to confirm cancer, but the costs often discourage patients from getting them. While costs across states. North Dakota had the highest out-of-pocket costs (51.8%), while Northeastern states like Delaware and New York had the lowest (9.0% and 12.9%, respectively). The financial burden has led many women to delay follow-up tests, potentially resulting in later-stage cancer diagnoses and higher treatment costs. Read more

    Federal Updates

    ​​​The Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act was introduced in the U.S. Senate by Senators John Boozman (R-AR) and Cory Booker (D-NJ). This bipartisan legislation would eliminate financial barriers to prostate cancer screening by waiving cost-sharing requirements—such as deductibles, copayments, and coinsurance—for high-risk individuals, including Black men and those with a family history of the disease. 

    The Medicare Multi-Cancer Early Detection Screening Coverage Act was introduced in the House and Senate​. Original sponsors in the Senate include Senators Mike Crapo (R-ID), Mike Bennet (D-CO), Tim Scott (R-SC), and Ron Wyden (D-OR), and in the House by Reps. Jodey Arrington (R-TX), Terri Sewell (D-AL), Richard Hudson (R-NC), Raul Ruiz (D-CA), Mariannette Miller-Meeks (R-IA), and Robin Kelly (D-IL). 

    ACS CAN continues to advocate for Congress to complete the FY25 spending bills with the highest possible increases for cancer research and prevention before the current funding patch or Continuing Resolution (CR) expires on March 14th. The One Voice Against Cancer (OVAC) coalition held its annual meeting on January 27th, during which Kathryn Bell, Senior Advisor and Health Policy Staffer for the Senate HELP Committee, shared her insights and outlook for the 119th Congress. A total of 34 coalition members participated in the meeting. 

    Access to Clinical Trials: ACS CAN led 21 other patient advocacy and professional societies in requesting a regulatory safe harbor from the Anti-Kickback Statute that would create more clarity that clinical trial sponsors can legally provide financial support to patients participating in cancer trials. Financial concerns keep many otherwise interested patients from participating, and ACS CAN has worked both legislatively and through regulatory opportunities such as this one to ensure all patients, regardless of financial means, can participate in research. 

    Judicial Updates ​​

    On January 10th, the United States Supreme Court announced its decision to grant the government's petition for certiorari in the Braidwood Management v. Becerra case. At the core of this case is the requirement under the Affordable Care States Preventive Services Task Force (USPSTF) with zero copay. ACS CAN led patient and medical professional organizations in filing an amicus curiae or "friend of the court" brief urging the Supreme Court to take the case and reverse the decision of the U.S. Court of Appeals for the Fifth Circuit as to the constitutionality of the provisions relating to the USPSTF. We argued that the ruling at stake threatens to drastically reduce use of preventive services such as life-saving colorectal and lung cancer screenings. ACS CAN will continue to stay fully engaged in the case, including leading an amicus brief on the merits (to be filed in February) noting that requiring co- pays for these USPSTF-recommended preventive services will create a cost barrier for many, reducing utilization, leading to worse patient outcomes as well as likely increased health care expenses in the long-term. 

    ​In January, ACS CAN led patient and physician groups in filing an amicus brief advocating for broad protections against discrimination for LQBTQ+ individuals in health care services under section 1557 of the Affordable Care Act. Courts had put a favorable rule issued by the Department of Health and Human Services (HHS) on hold, and the January filing marked the third case on this issue which ACS CAN had led amici briefs since late November. Unfortunately, Executive Orders issued in late January will likely result in the government not defending the rule in court and rescinding the rule. 

    On January 24, patient groups representing millions of individuals with serious diseases and health conditions submitted an amicus curiae brief urging the United States Court of Appeals for the Eighth Circuit to uphold Affordable Care Act insurance coverage eligibility to Deferred Action for Childhood Arrivals (DACA) recipients, as permitted by the HHS Final Rule issued in May 2024. In December of 2024, the Eighth Circuit lifted a temporary stay of the preliminary injunction in the case of Kansas v. United States. The injunction was issued following an appeal filed by the Centers for Medicare and Medicaid Services (CMS). As a result, DACA recipients are not able to enroll in Affordable Care Act (ACA) Marketplace plans in the 19 plaintiff states involved in the lawsuit. 

    ACS CAN continues to defend the Food and Drug Administration's (FDA) rule requiring graphic warnings on cigarette packages and advertisements in the endless battles surrounding the rule in court. Most recently, ACS CAN joined an amicus brief filed by tobacco control groups in January in the case of Philip Morris International v. FDA in a U.S. District Court in Georgia.  ​

    ​State Updates​ 

    In Ohio on January 23rd, Rep. Andrea White reintroduced legislation that would increase access to biomarker testing, which could help identify the most effective, patient-specific treatment. Despite its benefits, access to biomarker testing has not kept pace with the rate of innovation due to several barriers, including lack of coverage by private health insurance and Medicaid programs, which Rep. White's legislation would fix. 

    West Virginia has the highest adult smoking rate in the country and over 28% of West Virginia high school students use tobacco products. ACS CAN advocates are calling on Governor Morrisey and lawmakers to increase prevention funding. 

    Governor Mills proposed to increase the Maine cigarette tax by $1 per pack which would increase the tax revenue while at the same time substantially reduce longer term tobacco related health care costs. ACS CAN called on lawmakers to support this proposal. 

    ​Advocacy in the News

    • ​​Bloomberg: Cigarette Nicotine Cuts Proposed in Last-Minute FDA Rule

    • Axios: Lung cancer diagnoses in American women outpace men for first time 

    • Cancer Health: How Would Failing to Extend Tax Credits for Marketplace Health Plans Impact Cancer Patients? 

    • Healthcare Dive: New rule wipes medical debt from consumer credit reports 

    • Medical Economics: Lawmakers, experts weigh in on Medicare Drug Price Negotiation Program 

    • Black Information Network: Radio Segment Featuring ACS CAN Expert Dr. Bruce Waldholtz 

    • Voz: New cancer profile in America: Women and young people 

    • Bangor Daily News: Letter: Higher taxes on cigarettes will benefit Maine

    • Philadelphia Inquirer: New year, new laws: Health reforms hit Pa. and N.J. 

    • Mississippi Today: ‘It’s 2025’: Health care leaders plead with lawmakers to expand Medicaid​​

  • Four Hope Lodge locations launch ACS EMPOWER pilots

    The American Cancer Society began to pilot a new program, ACS EMPOWER, to four Hope Lodge locations in December, and there are plans to expand the program to all locations later this year. ACS EMPOWER is an interactive educational wellness and integrative health curriculum focused on improving the quality of life for Hope Lodge guests and those in the local community with cancer. The four pilot locations are Iowa City, IA; Jackson, MS; Jacksonville, FL; and Salt Lake City, UT. 

    “We recognized a need to further support people on their cancer journey, integrating a focus on whole-person health into the Hope Lodge experience; ACS EMPOWER is designed to help people elevate their quality of life by fostering resilience, connection, and well-being,” said Tamara Fernandez, vice president, Hope Lodge.

    ACS EMPOWER curriculum is comprised of seven core areas focused on the holistic well-being of people with cancer: 

    • Engage: Connect to knowledge and support communities, strengthen social networks, combat exclusion, and isolation
    • Move: Strengthen, energize, and destress with physical resilience activities 
    • Play: Harness the power and positive impact of fun at any age; evoke joy and laughter, reduce anxiety, and embrace teamwork 
    • Optimize: Position to achieve and maintain comprehensive physical and physiologic wellness during active treatment and beyond 
    • Waken: Elevate consciousness, unleash creativity, and embrace self-expression to support healing 
    • Enrich: Explore the benefits of complementary, functional, and integrative medicine principles, techniques, and programs 
    • ​Resource: Understand the array and availability of non-clinical support resources and health-related social needs programs. 

    The curriculum will allow each Hope Lodge community to tailor the program to fit the needs of its guests and create meaningful connections within the local community.

    "This program is going to revolutionize the Hope Lodge experience and create a brighter, stronger future for the patients and caregivers we serve,” added Tamara. 

    The varied EMPOWER activities include: 

    • Cooking demonstrations featuring nutritious, cancer-friendly meals 
    • Arts and crafts for creative expression and relaxation 
    • Live music and entertainment to uplift and inspire 
    • Massage therapy to support stress relief and healing 
    • Yoga and stretch exercises to enhance physical well-being 
    • ​Educational lectures on health, nutrition, and survivorship ​
    Looking Ahead 

    With its nationwide expansion planned for later this year, ACS EMPOWER represents a new era of integrative oncology support, ensuring that every Hope Lodge guest has access to comprehensive, whole-person care throughout their cancer journey. 

  • ACS CAN, patient groups urge access to health insurance for DACA recipients

    ​​On Jan. 24, the American Cancer Society Cancer Action Network (ACS CAN) along with other patient groups representing millions of individuals with serious diseases and health conditions submitted an amicus curiae (friend of the court) brief​ urging the U.S. Court of Appeals for the Eighth Circuit to uphold insurance coverage eligibility to Deferred Action for Childhood Arrivals (DACA) recipients, as permitted by the Department of Health and Human Services (HHS) Final Rule issued in May 2024. 

    In Dec. 2024, the Eighth Circuit lifted a temporary stay of the preliminary injunction in the case of Kansas v. United States, which was issued following an appeal filed by the Centers for Medicare and Medicaid Services (CMS). As a result, DACA recipients are not able to enroll in Affordable Care Act (ACA) Marketplace plans in the 19 plaintiff states involved in the lawsuit. 

    The groups on the brief, including ACS CAN, the American Lung Association, Epilepsy Foundation of America, the Leukemia & Lymphoma Society and the Muscular Dystrophy Association, issued the following statement on today’s filing: 

    “Access to affordable and comprehensive health insurance coverage strengthens public health by ensuring people are able to prevent, detect, treat, and survive serious diseases and health conditions. 

    “Since the ACA’s implementation, nearly 50 million people have gained coverage, slashing the rate of uninsured individuals to historic lows. However, approximately 34%​ of DACA recipients lack health insurance coverage even though they work and pay taxes that support the ACA. Before the injunction, the Final Rule was estimated to allow approximately 100,000​ DACA recipients to get health insurance through ACA marketplaces. 

    “Expanding coverage to DACA recipients makes our health system stronger and benefits everyone by lowering uncompensated care costs, reducing the number of individuals who rely on expensive emergency services and contributing to insurance pools with a population that is, on average, younger and healthier. Therefore, we urge the Court of Appeals to uphold granting DACA recipients critical access to affordable health insurance coverage and the peace of mind it provides.” 

    The organizations are represented on a pro bono basis by the law firm of Wilentz, Goldman & Spitzer. 

back to top